Navigation Links
Allied Healthcare Announces Litholyme(TM) -- New CO2 Absorbent Used in Anesthesia
Date:6/17/2010

ll," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.


'/>"/>
SOURCE Allied Healthcare Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions
2. Recession Continues to Depress Sales at Allied Healthcare Products
3. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
4. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
5. CSafe Signs Master Lease With Cathay Pacific Airways to Further Enhance Healthcare and Pharmaceutical Transport
6. GHX OnDemand AP(R) Solution Improves Cash Flow, Streamlines Invoice Processing for Healthcare Providers
7. Healthcare Equipment & Services Research June Updates by MarketPublishers.com
8. Henry Schein to Present at the Goldman Sachs 31st Annual Global Healthcare Conference
9. Isis Pharmaceuticals to Present at The Wells Fargo 2010 Healthcare Conference
10. Obamas Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets (Pharmaceuticals, Medical Devices and Health Insurance)
11. Perrigo Company to Present at the 31st Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... DALLAS , July 3, 2015 ... report "Cardiac Monitoring & Cardiac Rhythm Management Market ... Output Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber ... published by MarketsandMarkets, the global Cardiac Monitoring (CM) ... poised to reach $26,646.5 Million by 2020 from ...
(Date:7/3/2015)... 2015 A global continuing medical ... and thyroid disorders in Latin America ... conference dedicated to these diseases.      (Logo: ... Manage Hypertension Online and Manage Thyroid ... EXCEMED - combine the world,s top expertise with ...
(Date:7/3/2015)... , July 3, 2015  Obsidian HDS, the ... an online service for the management of data on ... today that PharmaShine now includes the 2014 Open Payments ... Medicare Services on June 30. The data disclosed on ... transactions between industry and providers totaling $6.49 billion and ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... Phase 3 Once Weekly Investigational Diabetes Therapy Also Improved ... from Exenatide Taken Twice a Day, SAN FRANCISCO, ... Eli Lilly and Company (NYSE: LLY ), and ... a 52-week open-label clinical,study that showed the durable efficacy ...
... VIEW, Calif., June 9 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... Phase 2a proof-of-concept clinical trial with AZ-002 (Staccato(R),alprazolam) ... not meet its two,primary endpoints, which were the ... panic attack and the effect of AZ-002 on ...
Cached Medicine Technology:After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 2After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 3After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 4After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 5After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 7After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 8After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 9Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 2Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 3Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 4
(Date:7/3/2015)... ... ... rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich , has ... from March 4th - 6th, the 2016 (a previous announcement had stated the dates ... take participants from the basic training and fundamentals of nasal surgery through the most ...
(Date:7/3/2015)... CT (PRWEB) , ... July 03, 2015 , ... Smoothies ... home is a good blender and easily accessible, quality ingredients. Aurora Natural is proud ... smoothie for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ” was featured ... coolest technology products available to consumers. Amanda Forstrom, a technology expert and special reporter ... great for documenting memories. , Almost every smartphone has an incredibly powerful camera built ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Mississippi. The premium frozen yogurt chain was listed as #22 on the Inc. 500 ... Avenue, New Albany, MS 38652, will have a grand opening event on July 4, ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Edwards (D-Md.) for her introduction of the Stop Overdose Stat (S.O.S.) Act of ... Senator Jack Reed (D-R.I.), this Act seeks to decrease drug overdose – especially ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3
... with colon cancer that has advanced beyond the early ... according to a recent study. In addition to an ... have an increased risk of cancer recurrence, at least ... outcomes and treatment-related side effects in colon cancer patients ...
... ovarian cancer in women at high risk for the ... of the risk reduction depends upon the type and ... rate of all gynecological cancer and few preventive or ... ovarian cancer is a family member who has been ...
... black cohosh is an effective way to relieve menopausal ... be safe for women with breast cancer or women ... School of Pharmacy at Duquesne University studied how the ... did not increase the incidence of new tumors but ...
... a gene mutation that may cause premature ovarian failure, or ... into, what researchers say, is a poorly understood condition. ,Premature ... 250,000 women in the United States. It is diagnosed in ... Investigators created mice that lack both copies of a gene ...
... hope for the millions of people throughout the world ... form of eczema marked by frequent, unpredictable relapses. It ... potent topical corticosteroid followed by a lower potency preparation ... of topical corticosteroids followed by a maintenance regimen using ...
... to give up many of the activities to which you ... not being able to go places that aren’t wheelchair accessible ... new research in Philadelphia brings paralyzed people a little closer ... something amazing happens to Les Kirk.,Instead of us doing it ...
Cached Medicine News:
... Flat is designed for routine ... induction of posterior vitreous detachments. ... macula whole surgery, epiretinal membranes ... epiretinal membranes. Direct image lens ...
The Mid Field lens can be used for air/gas exchange and has a bi-concave design to provide the widest field available in a direct image surgical lens....
... and increased stereopsis, the Central Retinal ACS ... the equatorial regions. The Central Retinal is ... membrane peeling in proliferative vitreoretinopathy extending to ... ACS Vitrectomy Lenses from Volk can be ...
... patented ACS lenses offer the high resolution, ... the original clariVits. The simple two part ... its integrity during surgery. Simply autoclave, add ... then lock together for use. (ACS) AutoClave ...
Medicine Products: